Janice Rice assists clients with their intellectual property needs in the fields of chemistry, diagnostics and personalized medicine. She has managed portfolios covering small molecules, peptides, oligosaccharides, small molecule-antibody conjugates, polymorphs, formulations and process chemistry. Her practice includes patent drafting and prosecution, developing US and international patent strategies, evaluation and protection of trade secrets, patentability and freedom to operate analyses, patent due diligence and advising on intellectual property licensing issues.
Before joining Squire Patton Boggs, for more than 12 years Janice worked in-house representing pharmaceutical companies with compounds at all stages of development, ranging from preclinical to approved drugs. She has a deep understanding of the pharmaceutical industry and the intersection of business objectives and patent strategy. In her work she has advised clients on IP-related regulatory issues, product life cycle management, and the handling of inventions made overseas. Her in-house work included representing companies in collaborations with institutes, universities and large pharmaceutical companies.
Prior to her legal career, Janice worked for nine years as a synthetic organic chemist at a pharmaceutical company and later at a contract research organization. She is the author of numerous scientific publications and has presented some of her research at an American Chemical Society meeting.